Journals in Immunology

Elsevier's Immunology collection equips researchers with valuable insights to address the complexities of the immune system and its role in health and disease, offering original research, insightful analysis, and current theory on diagnosing, managing, and advancing treatments for allergies, asthma, and immunologic disorders.

Books Journals

Life Sciences

ISSN: 0024-3205
5 Year impact factor: 5.3
Impact factor: 5.2

Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.Manuscripts should present novel preclinical findings addressing questions of biological significance to human disease. Studies that fail to do so may be rejected without review. Quantitative conclusions must be based on truly quantitative methods. Life Sciences does not publish work on the actions of biological extracts of unknown chemical composition. Compounds studied must be of known chemical structure and concentration. The study must be reproducible; materials used must be available to other researchers so they can repeat the experiment. Clinical studies may be considered if they expand understanding of mechanism, but the journal does not encourage clinical trial reports.Four common reasons for rejection include: out of scope (the manuscript does not conform to the goal of identification of mechanisms related to therapy for human disease); too preliminary (manuscript is based on a limited amount of experimental data diminishing significance); lack of novelty (manuscript is well done but does not address a significant question); unidentified structure (actions of biological extracts of unknown chemical composition).

Subscriptions

Microbes and Infection

ISSN: 1286-4579
5 Year impact factor: 3
Impact factor: 2.6

A Journal on Infectious Agents and Host Defenses A publication of the Institut PasteurThis journal has no page charges, publication is free of charge.Microbes and Infection publishes 8 peer-reviewed issues per year in all fields of infection and immunity, covering the different levels of host-microbe interactions, and in particular:the molecular biology and cell biology of the crosstalk between hosts (human and model organisms) and microbes (viruses, bacteria, parasites and fungi), including molecular virulence and evasion mechanisms.the immune response to infection, including pathogenesis and host susceptibility.emerging human infectious diseases.systems immunology.molecular epidemiology/genetics of host pathogen interactions.microbiota and host "interactions".vaccine development, including novel strategies and adjuvants.Clinical studies, accounts of clinical trials and biomarker studies in infectious diseases, unless purely descriptive, are within the scope of the journal.Microbes and Infection publishes articles on human pathogens or pathogens of model systems. However, articles on other microbes can be published if they contribute to our understanding of basic mechanisms of host-pathogen interactions. Purely descriptive and preliminary studies are discouraged.Reviews of a major topic of current interest must be commissioned by a Microbes and Infection editor. Unsolicited contributions and presubmission enquiries will not be considered.Special issues focus on the present knowledge of a virulent microbe and the disease it causes, the immune response in infectious disease, or on critical issues relevant to the scope of the journal.The journal is entering its 20th year of publication, and Essential Science IndicatorsSM (ESI) states that "Microbes and Infection has had a significant impact in the field of Immunology." https://www.editorialmanager.com/MICINF/default.aspxhttps://www.pasteur.fr/fr/ceris/publications-scientifiques/microbes-infectionThe full-text articles, etc, are available at:https://www.sciencedirect.com/journal/microbes-and-infection

Subscriptions

Microbial Pathogenesis

ISSN: 0882-4010
5 Year impact factor: 3.6
Impact factor: 3.3

Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.Research Areas Include:PathogenesisVirulence factorsHost susceptibility or resistanceImmune mechanismsIdentification, cloning and sequencing of relevant genesGenetic studiesViruses, prokaryotic organisms and protozoaMicrobiotaSystems biology related to infectious diseasesTargets for vaccine design (pre-clinical studies)The journal aims for rapid publication of articles of high quality and significance in an international forum. Please note that reviews are only accepted upon editorial invitation.Short Communications have the following limits. The manuscript should ideally contain no more than 4-6 Figures/Tables and 4000 words, including the title page, all sections of the manuscript (including the references), and Figure/Table legends. The abstract should be limited to 200 words.Microbial Pathogenesis does not accept submissions that primarily consist of (a) bioinformatics or computational analysis of public genomic or transcriptomic databases, or (b) the testing and evaluation of previously uncharacterized natural product-based drug candidates. The journal does not publish purely bioinformatic or computational studies without substantial experimental validation. Please be aware that experimental validation is a mandatory requirement for all submissions.

Subscriptions

Molecular Immunology

ISSN: 0161-5890
5 Year impact factor: 3.6
Impact factor: 3.2

Molecular Immunology publishes original articles, reviews and commentaries on all areas of immunology, with a particular focus on description of cellular, biochemical or genetic mechanisms underlying immunological phenomena. Studies on all model organisms, from invertebrates to humans, are suitable. Examples include, but are not restricted to:Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunologyMechanisms of induction, regulation and termination of innate and adaptive immunityIntercellular communication, cooperation and regulationIntracellular mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, etc)Mechanisms of action of the cells and molecules of the immune systemStructural analysisDevelopment of the immune systemComparative immunology and evolution of the immune system"Omics" studies and bioinformaticsVaccines, biotechnology and therapeutic manipulation of the immune system (therapeutic antibodies, cytokines, cellular therapies, etc)Technical developmentsArticles based primarily on studies in silico must adhere to the following principles; (i) The article must report novel analytical tools, approaches and/or databases rather than using publicly available ones; or (ii) The article must include substantial experimental validation of the conclusions obtained in silico.Manuscripts related to regulatory RNA (e.g. microRNAs, lncRNAs or circRNAs) are welcome but please note: (i) they must show clear physiological relevance supported by in vivo results or clinical observations; (ii) Correlations between regulatory RNA expression with human diseases should be experimentally validated; (iii) Functions associated with the regulatory RNAs must within the scope of the journal i.e. inflammation and/or immune responses.To be acceptable for publication, studies that describe correlations between disease and genetic polymorphisms would normally be required to include novel mechanistic findings underlying the associations.Clinical studies correlating disease and measurements of a molecule or cell type would likewise not be suitable for publication without novel mechanistic insights.Studies describing pharmacological agents are welcome if they provide significant novelty on the mechanisms of action.

Subscriptions

Molecular and Biochemical Parasitology

ISSN: 0166-6851
5 Year impact factor: 1.6
Impact factor: 1.4

Molecular and Biochemical Parasitology provides a medium for rapid publication of investigations of the molecular biology and biochemistry of parasitic protozoa and helminths and their molecular interactions with their definitive and intermediate hosts and their vectors.The main subject areas covered are:the structure, biosynthesis, degradation, properties and function of parasite biomolecules - DNA, RNA, proteins, lipids, carbohydrates and small molecular-weight substanceshost-parasite relationships particularly as related to specific parasite molecules and to the response of host cells to infectionvector-parasite relationships at the molecular levelintermediary metabolism and bioenergeticsdrug target characterization and the mode of action of antiparasitic drugsanalysis of gene function, expression, and of genome structure and stabilityanalysis of variation in parasite populations relevant to genetic exchange, pathogenesis, drug and vaccine target characterization, and drug resistance; please note that genetic variation data must be supported by phenotypic/experimental data showing the effect of the variation, and that papers reporting solely on allele frequencies in specific regions will not be accepted.parasite protein trafficking, organelle biogenesis, and cellular structure especially with reference to the roles of specific moleculesmolecular and biochemical aspects of membrane structure and functionparasite programmed cell death, development, and cell division at the molecular levelmethods reports - descriptions of novel or newly-optimized methods with broad applicability to molecular and biochemical parasitologyPapers will only be accepted for publication if they fall within these areas, if they contain original and complete work of high scientific quality, and if they are well presented. Papers solely confirming the conserved functions of genes previously studied in other organisms will not be considered. We welcome short communications documenting a succinct but clear and important advance.1. Original research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words per article (all text excluding tables and figure legends).2. Short Communications need not be formally structured as full papers but should describe significant new findings and observations. The manuscript should ideally contain no more than 4Figures/Tables and 3000 words. The abstract should be limited to 200 words.3. Methods Reports should contain descriptions of novel or newly-optimised methods with broad applicability to molecular parasitologists. The manuscript should ideally contain no more than 4 Figures/Tables and 3000 words. Results and Discussion are usually combined. The abstract should be limited to 200 words. Methods Reports must include a detailed step-by-step protocol and/or analysis code in the supplementary material.4. Review articles should cover subjects falling within the scope of the journal which are of active current interest. They may be submitted or invited by the Editors. Review articles should include insightful recommendations for future directions needed for achieving public health impacts. Review articles are limited to 15,000 words per article (all text excluding tables and figure legends). If you have a suggestion for a Review article topic please email Special Content Editor, Geoff Gobert: [email protected]. Perspective articles should include scientifically backed points of view regarding currently relevant, controversial or future-oriented topics pertinent to the scope of MBP. Note that only outlining recent advances in a given field is not acceptable for a Perspective article. Besides stimulating scientific discussion or future research, perspective articles should provide a novel conceptual framework for an old or timely issue. The authors should outline which research directions should be prioritized and highlight specific points explaining why they should be prioritized in future research. Perspective articles are limited to 6,000 words per article (all text excluding tables and figure legends).6. Letters to the Editor offering comment or useful critique on material published in the journal are welcome. Letters on "hot topics" are also welcome. Note that Letters to the Editors will also be externally reviewed but the decision to publish submitted letters rests with the Editors in Chief. A goal is to publish constructive letters that will permit an exchange of views which will be of benefit to both the journal and its readers. Letters to the Editor are limited to 2,000 words per article (all text excluding tables and figure legends).Most downloaded papersBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Next Research

ISSN: 3050-4759

Next Research is a peer-reviewed multidisciplinary journal, publishing research spanning all scientific technical and medical communities.The journal is part of the Next family, a new suite of multidisciplinary journals from Elsevier spanning all branches of science. Managed by our dedicated team of in-house Editors, Next Research offers authors speed, consistency, innovation, flexibility, and ease of submission.Next Research is an inclusive venue for scientifically accurate manuscripts that meet the ethical and scientific publishing standards. It publishes all research topics across the fields of health sciences, physical sciences, life sciences and social sciences. Next Research publishes experimental, computational, and theoretical work, in traditional formats such as Original Research Articles, Communications and Reviews, as well as novel formats and video content.The journal provides authors with rigorous peer review ensuring articles adhere to a high technical standard, with rapid decisions and a highly visible platform for scientists to share their research.We believe that all rigorous research should be shared.

Subscriptions

Parasitology International

ISSN: 1383-5769
5 Year impact factor: 1.6
Impact factor: 1.5

The Official, International Journal of the Japanese Society of ParasitologyParasitology International provides a medium for rapid, carefully reviewed publications in the field of human and animal parasitology. Original papers, rapid communications, and original case reports from all geographical areas and covering all parasitological disciplines, including structure, immunology, cell biology, biochemistry, molecular biology, and systematics, may be submitted. Reviews on recent developments are invited regularly, but suggestions in this respect are welcome. Letters to the Editor commenting on any aspect of the Journal are also welcome.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Seminars in Immunology

ISSN: 1044-5323
5 Year impact factor: 10
Impact factor: 7.4

Review articles in Seminars in Immunology are by invitation only.Seminars in Immunology is a review journal dedicated to keeping scientists informed of developments in the field of immunology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to immunologists, focusing on recent advances across a broad spectrum of research, from the molecular and cellular basis of the immune response to the possibilities for its manipulation. Every issue is edited by a guest editor, an internationally acknowledged expert in the field, and contains six to eight authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency. Topics Covered in Earlier Issues Include:• Mechanism of V(D)J rearrangement • Commitment to CD4 and CD8 lineages • Mechanisms of T cell help • Lessons from the LPR mouse • Phosphatidylinositol-linked molecules in T-cell activationBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

The Lancet

ISSN: 0140-6736
5 Year impact factor: 106.9
Impact factor: 98.4

The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.

Subscriptions

Transplant Immunology

ISSN: 0966-3274
5 Year impact factor: 1.5
Impact factor: 1.6

Transplant Immunology will publish up-to-date information on all aspects of the broad field it encompasses. The journal is directed to general scientific and medical audience but in particular to basic and applied scientists, transplant-related laboratory personnel, transplant physicians and surgeons. The journal will present research reports and clinical data on all immunological aspects of organ-, tissue-, and haematopoietic stem cell transplantation. Furthermore, the journal is interested to publish high quality basic and clinical research in immunology, physiology and pathophysiology related to processes and diseases affecting transplant patients. Original papers, Brief reports, Cases reports and Review articles and Hypotheses will be considered for publication. Submitted manuscripts will be rapidly peer-reviewed and published. They will be judged on the basis of scientific merit, originality, timeliness and quality.

Subscriptions

Related subjects

Applied immunology

Basic immunology

Immunological methods

Immunopathogenesis

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Immunology

Life Sciences

Microbes and Infection

Microbial Pathogenesis

Molecular Immunology

Molecular and Biochemical Parasitology

Next Research

Parasitology International

Seminars in Immunology

The Lancet

Transplant Immunology

Related subjects